Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results
Completed
Conditions studied: Cervical Cancer
In brief
RATIONALE: Examining biomarkers in abnormal cervical cells may improve the ability to detect these cells and plan effective treatment. PURPOSE: Diagnostic trial to detect specific biomarkers in abnormal cervical cells in women who have abnormal Pap test results.
Key facts
- Study ID
- NCT00004091
- Run by
- Northwestern University
- People needed
- 100
- Starts
- 1999-08-01
- Expected to finish
- 2001-02-01
- Last updated by the study team
- 2011-01-31
Who can join
Age: any. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.